Literature DB >> 21603789

Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.

Luiz Guilherme Darrigo Júnior1, Elvis Terci Valera, André de Aboim Machado, Antonio Carlos Dos Santos, Carlos Alberto Scrideli, Luiz Gonzaga Tone.   

Abstract

CONTEXT: Neurofibromatosis type 1 (NF-1) is the most prevalent autosomal dominant genetic disorder among humans. Moyamoya disease is a cerebral vasculopathy that is only rarely observed in association with NF-1, particularly in the pediatric age range. The present study reports an occurrence of this association in an infant. CASE REPORT: An eight-month-old female presented convulsive seizures with clonic movements. The patient suffered an ischemic stroke with hemiparesis. Magnetic resonance imaging revealed radiological findings compatible with moyamoya disease. The diagnosis of NF-1 was made at the age of 20 months.
CONCLUSION: Despite the rarity of this association in childhood, children with focal neurological symptoms and a diagnosis of NF-1 deserve to be investigated for moyamoya syndrome.

Entities:  

Mesh:

Year:  2011        PMID: 21603789     DOI: 10.1590/s1516-31802011000200010

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  6 in total

1.  Epilepsy in NF1: a systematic review of the literature.

Authors:  Pia Bernardo; Giuseppe Cinalli; Claudia Santoro
Journal:  Childs Nerv Syst       Date:  2020-07-01       Impact factor: 1.475

Review 2.  Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.

Authors:  Felice D'Arco; Alessandra D'Amico; Ferdinando Caranci; Nilde Di Paolo; Daniela Melis; Arturo Brunetti
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

Review 3.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

4.  Moyamoya syndrome and neurofibromatosis type 1.

Authors:  Euthymia Vargiami; Evdoxia Sapountzi; Dimitris Samakovitis; Spyros Batzios; Maria Kyriazi; Athanasia Anastasiou; Dimitrios I Zafeiriou
Journal:  Ital J Pediatr       Date:  2014-06-21       Impact factor: 2.638

Review 5.  Phakomatoses and cutaneous manifestations associated with moyamoya disease and syndrome.

Authors:  Maja Tomaszewska; Lidia Strzelczuk-Judka; Danuta Ostalska-Nowicka; Katarzyna Jończyk-Potoczna
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

Review 6.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.